Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Fentanyl 25micrograms/hour transdermal patches
0407020A0AAAEAE
|
Fentanyl | Fentanyl | Central Nervous System | 15,120 |
|
Fentanyl 12micrograms/hour transdermal patches
0407020A0AAAUAU
|
Fentanyl | Fentanyl | Central Nervous System | 14,727 |
|
Fentanyl 50micrograms/hour transdermal patches
0407020A0AAAFAF
|
Fentanyl | Fentanyl | Central Nervous System | 7,415 |
|
Fentanyl 37.5microgram/hour transdermal patches
0407020A0AABWBW
|
Fentanyl | Fentanyl | Central Nervous System | 6,959 |
|
Fentanyl 75micrograms/hour transdermal patches
0407020A0AAAGAG
|
Fentanyl | Fentanyl | Central Nervous System | 2,953 |
|
Fentanyl 100micrograms/hour transdermal patches
0407020A0AAAHAH
|
Fentanyl | Fentanyl | Central Nervous System | 2,645 |
|
Fentanyl 200microgram lozenges
0407020A0AAAIAI
|
Fentanyl | Fentanyl | Central Nervous System | 535 |
|
Fentanyl 400microgram lozenges
0407020A0AAAJAJ
|
Fentanyl | Fentanyl | Central Nervous System | 345 |
|
Fentanyl 100microgram sublingual tablets sugar free
0407020A0AAAWAW
|
Fentanyl | Fentanyl | Central Nervous System | 318 |
|
Fentanyl 100microgram buccal tablets sugar free
0407020A0AABCBC
|
Fentanyl | Fentanyl | Central Nervous System | 296 |
|
Fentanyl 200microgram sublingual tablets sugar free
0407020A0AAAXAX
|
Fentanyl | Fentanyl | Central Nervous System | 256 |
|
Fentanyl 200microgram buccal tablets sugar free
0407020A0AABDBD
|
Fentanyl | Fentanyl | Central Nervous System | 242 |
|
Fentanyl 600microgram lozenges
0407020A0AAAKAK
|
Fentanyl | Fentanyl | Central Nervous System | 189 |
|
Fentanyl 400microgram buccal tablets sugar free
0407020A0AABEBE
|
Fentanyl | Fentanyl | Central Nervous System | 149 |
|
Fentanyl 400microgram sublingual tablets sugar free
0407020A0AAAZAZ
|
Fentanyl | Fentanyl | Central Nervous System | 111 |
|
Fentanyl 800microgram lozenges
0407020A0AAALAL
|
Fentanyl | Fentanyl | Central Nervous System | 60 |
|
Fentanyl 100micrograms/dose nasal spray
0407020A0AABJBJ
|
Fentanyl | Fentanyl | Central Nervous System | 46 |
|
Fentanyl 300microgram sublingual tablets sugar free
0407020A0AAAYAY
|
Fentanyl | Fentanyl | Central Nervous System | 41 |
|
Fentanyl 800microgram sublingual tablets sugar free
0407020A0AABBBB
|
Fentanyl | Fentanyl | Central Nervous System | 31 |
|
Fentanyl 600microgram buccal tablets sugar free
0407020A0AABFBF
|
Fentanyl | Fentanyl | Central Nervous System | 30 |
|
Fentanyl 1.6mg lozenges
0407020A0AAAPAP
|
Fentanyl | Fentanyl | Central Nervous System | 26 |
|
Fentanyl 600microgram sublingual tablets sugar free
0407020A0AABABA
|
Fentanyl | Fentanyl | Central Nervous System | 26 |
|
Fentanyl 800microgram buccal tablets sugar free
0407020A0AABGBG
|
Fentanyl | Fentanyl | Central Nervous System | 20 |
|
Fentanyl 400micrograms/dose nasal spray
0407020A0AABPBP
|
Fentanyl | Fentanyl | Central Nervous System | 10 |
|
Fentanyl 1.2mg lozenges
0407020A0AAANAN
|
Fentanyl | Fentanyl | Central Nervous System | 9 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.